-
1
-
-
6944244084
-
A module map showing conditional activity of expression modules in cancer
-
DOI 10.1038/ng1434
-
E. Segal, N. Friedman, D. Koller, and A. Regev A module map showing conditional activity of expression modules in cancer Nat. Genet. 36 10 2004 1090 1098 (Pubitemid 41184471)
-
(2004)
Nature Genetics
, vol.36
, Issue.10
, pp. 1090-1098
-
-
Segal, E.1
Friedman, N.2
Koller, D.3
Regev, A.4
-
2
-
-
33750605893
-
Tumor-associated antigen arrays for the serological diagnosis of cancer
-
DOI 10.1074/mcp.R600010-MCP200
-
C.A. Casiano, M. Mediavilla-Varela, and E.M. Tan Tumor-associated antigen arrays for the serological diagnosis of cancer Mol. Cell. Proteomics 5 10 2006 1745 1759 (Pubitemid 44688185)
-
(2006)
Molecular and Cellular Proteomics
, vol.5
, Issue.10
, pp. 1745-1759
-
-
Casiano, C.A.1
Mediavilla-Varela, M.2
Tan, E.M.3
-
3
-
-
4644289323
-
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
-
DOI 10.1073/pnas.0405884101
-
Y. Oka, A. Tsuboi, T. Taguchi, T. Osaki, T. Kyo, H. Nakajima, O.A. Elisseeva, Y. Oji, M. Kawakami, K. Ikegame, N. Hosen, S. Yoshihara, F. Wu, F. Fujiki, M. Murakami, T. Masuda, S. Nishida, T. Shirakata, S. Nakatsuka, A. Sasaki, K. Udaka, H. Dohy, K. Aozasa, S. Noguchi, I. Kawase, and H. Sugiyama Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Proc. Natl Acad. Sci. U. S. A. 101 38 2004 13885 13890 (Pubitemid 39298502)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.38
, pp. 13885-13890
-
-
Oka, Y.1
Tsuboi, A.2
Taguchi, T.3
Osaki, T.4
Kyo, T.5
Nakajima, H.6
Elisseeva, O.A.7
Oji, Y.8
Kawakami, M.9
Ikegame, K.10
Hosen, N.11
Yoshihira, S.12
Wu, F.13
Fujiki, F.14
Murakami, M.15
Masuda, T.16
Nishida, S.17
Shirakata, T.18
Nakatsuka, S.-I.19
Sasaki, A.20
Udaka, K.21
Dohy, H.22
Aozasa, K.23
Noguchi, S.24
Kawase, I.25
Sugiyama, H.26
more..
-
4
-
-
0037818503
-
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
-
DOI 10.1182/blood-2002-08-2554
-
S.M. Schmidt, K. Schag, M.R. Müller, M.M. Weck, S. Appel, L. Kanz, F. Grünebach, and P. Brossart Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells Blood 102 2 2003 571 576 (Pubitemid 36841977)
-
(2003)
Blood
, vol.102
, Issue.2
, pp. 571-576
-
-
Schmidt, S.M.1
Schag, K.2
Muller, M.R.3
Weck, M.M.4
Appel, S.5
Kanz, L.6
Grunebach, F.7
Brossart, P.8
-
6
-
-
0029100024
-
+T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4
-
+T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4 J. Immunol. 155 3 1995 1032 1036
-
(1995)
J. Immunol.
, vol.155
, Issue.3
, pp. 1032-1036
-
-
Kearney, E.R.1
Walunas, T.L.2
Karr, R.W.3
Morton, P.A.4
Loh, D.Y.5
Bluestone, J.A.6
Jenkins, M.K.7
-
7
-
-
33644831362
-
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
-
H. Shen, A.L. Ackerman, V. Cody, A. Giodini, E.R. Hinson, P. Cresswell, R.L. Edelson, W.M. Saltzman, and D.J. Hanlon Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles Immunology 117 1 2006 78 88
-
(2006)
Immunology
, vol.117
, Issue.1
, pp. 78-88
-
-
Shen, H.1
Ackerman, A.L.2
Cody, V.3
Giodini, A.4
Hinson, E.R.5
Cresswell, P.6
Edelson, R.L.7
Saltzman, W.M.8
Hanlon, D.J.9
-
8
-
-
21744448012
-
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
-
DOI 10.1016/j.jconrel.2005.02.027, PII S0168365905000969
-
Y.J. Kwon, S.M. Standley, S.L. Goh, and J.M. Fréchet Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles J. Control. Release 105 3 2005 199 212 (Pubitemid 40941986)
-
(2005)
Journal of Controlled Release
, vol.105
, Issue.3
, pp. 199-212
-
-
Kwon, Y.J.1
Standley, S.M.2
Goh, S.L.3
Frechet, J.M.J.4
-
10
-
-
27744580069
-
Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with L-phenylalanine as a protein carrier
-
DOI 10.1016/j.jconrel.2005.08.003, PII S0168365905003573
-
T. Akagi, T. Kaneko, T. Kida, and M. Akashi Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier J. Control. Release 108 2-3 2005 226 236 (Pubitemid 41608656)
-
(2005)
Journal of Controlled Release
, vol.108
, Issue.2-3
, pp. 226-236
-
-
Akagi, T.1
Kaneko, T.2
Kida, T.3
Akashi, M.4
-
11
-
-
39249084875
-
Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: A new tumor-vaccine carrier for eliciting effector T cells
-
T. Yoshikawa, N. Okada, A. Oda, K. Matsuo, K. Matsuo, H. Kayamuro, Y. Ishii, T. Yoshinaga, T. Akagi, M. Akashi, and S. Nakagawa Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells Vaccine 26 10 2008 1303 1313
-
(2008)
Vaccine
, vol.26
, Issue.10
, pp. 1303-1313
-
-
Yoshikawa, T.1
Okada, N.2
Oda, A.3
Matsuo, K.4
Matsuo, K.5
Kayamuro, H.6
Ishii, Y.7
Yoshinaga, T.8
Akagi, T.9
Akashi, M.10
Nakagawa, S.11
-
12
-
-
0032724112
-
Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma
-
F. Wang, E. Bade, C. Kuniyoshi, L. Spears, G. Jeffery, V. Marty, S. Groshen, and J. Weber Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma Clin. Cancer Res. 5 10 1999 2756 2765 (Pubitemid 29493949)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.10
, pp. 2756-2765
-
-
Wang, F.1
Bade, E.2
Kuniyoshi, C.3
Spears, L.4
Jeffery, G.5
Marty, V.6
Groshen, S.7
Weber, J.8
-
13
-
-
0028116790
-
Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation
-
Y. Li, Y. Ke, P.D. Gottlieb, and J.A. Kapp Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation J. Leukoc. Biol. 56 5 1994 616 624 (Pubitemid 24348822)
-
(1994)
Journal of Leukocyte Biology
, vol.56
, Issue.5
, pp. 616-624
-
-
Li, Y.1
Ke, Y.2
Gottlieb, P.D.3
Kapp, J.A.4
-
14
-
-
0028052101
-
Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules
-
C.V. Harding, and R. Song Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules J. Immunol. 153 11 1994 4925 4933 (Pubitemid 24356123)
-
(1994)
Journal of Immunology
, vol.153
, Issue.11
, pp. 4925-4933
-
-
Harding, C.V.1
Song, R.2
-
15
-
-
0036876410
-
Type 1 and type 2 responses in regulation of Ig isotype expression in cattle
-
DOI 10.1016/S0165-2427(02)00201-5, PII S0165242702002015
-
D.M. Estes, and W.C. Brown Type 1 and type 2 responses in regulation of Ig isotype expression in cattle Vet. Immunol. Immunopathol. 90 1-2 2002 1 10 (Pubitemid 36160480)
-
(2002)
Veterinary Immunology and Immunopathology
, vol.90
, Issue.1-2
, pp. 1-10
-
-
Estes, D.M.1
Brown, W.C.2
-
16
-
-
0032520727
-
The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice
-
DOI 10.1016/S0022-1759(98)00015-5, PII S0022175998000155
-
R.M. Martin, J.L. Brady, and A.M. Lew The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice J. Immunol. Meth. 212 2 1998 187 192 (Pubitemid 28288356)
-
(1998)
Journal of Immunological Methods
, vol.212
, Issue.2
, pp. 187-192
-
-
Martin, R.M.1
Brady, J.L.2
Lew, A.M.3
-
17
-
-
0035052853
-
Tumours can act as adjuvants for humoral immunity
-
DOI 10.1046/j.1365-2567.2001.01213.x
-
D.M. Brown, T.L. Fisher, C. Wei, J.G. Frelinger, and E.M. Lord Tumours can act as adjuvants for humoral immunity Immunology 102 4 2001 486 497 (Pubitemid 32322961)
-
(2001)
Immunology
, vol.102
, Issue.4
, pp. 486-497
-
-
Brown, D.M.1
Fisher, T.L.2
Wei, C.3
Frelinger, J.G.4
Lord, E.M.5
-
18
-
-
37449022610
-
Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine: Potential of the nanoparticulate cytosolic protein delivery carrier
-
DOI 10.1016/j.bbrc.2007.11.153, PII S0006291X07025570
-
T. Yoshikawa, N. Okada, A. Oda, K. Matsuo, K. Matsuo, Y. Mukai, Y. Yoshioka, T. Akagi, M. Akashi, and S. Nakagawa Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier Biochem. Biophys. Res. Commun. 366 2 2008 408 413 (Pubitemid 50010411)
-
(2008)
Biochemical and Biophysical Research Communications
, vol.366
, Issue.2
, pp. 408-413
-
-
Yoshikawa, T.1
Okada, N.2
Oda, A.3
Matsuo, K.4
Matsuo, K.5
Mukai, Y.6
Yoshioka, Y.7
Akagi, T.8
Akashi, M.9
Nakagawa, S.10
-
19
-
-
13844267658
-
PLA-PEG particles as nasal protein carriers: The influence of the particle size
-
DOI 10.1016/j.ijpharm.2004.09.002
-
A. Vila, A. Sánchez, C. Evora, I. Soriano, O. McCallion, and M.J. Alonso PLA-PEG particles as nasal protein carriers: the influence of the particle size Int. J. Pharm. 292 1-2 2005 43 52 (Pubitemid 40255787)
-
(2005)
International Journal of Pharmaceutics
, vol.292
, Issue.1-2
, pp. 43-52
-
-
Vila, A.1
Sanchez, A.2
Evora, C.3
Soriano, I.4
McCallion, O.5
Alonso, M.J.6
-
20
-
-
0037223094
-
HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses
-
G. Sakaue, T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses J. Immunol. 170 1 2003 495 502 (Pubitemid 36026176)
-
(2003)
Journal of Immunology
, vol.170
, Issue.1
, pp. 495-502
-
-
Sakaue, G.1
Hiroi, T.2
Nakagawa, Y.3
Someya, K.4
Iwatani, K.5
Sawa, Y.6
Takahashi, H.7
Honda, M.8
Kunisawa, J.9
Kiyono, H.10
-
21
-
-
4544258068
-
Nalt-versus Peyer's-patch-mediated mucosal immunity
-
DOI 10.1038/nri1439
-
H. Kiyono, and S. Fukuyama NALT- versus Peyer's-patch-mediated mucosal immunity Nat. Rev. Immunol. 4 9 2004 699 710 (Pubitemid 39223076)
-
(2004)
Nature Reviews Immunology
, vol.4
, Issue.9
, pp. 699-710
-
-
Kiyono, H.1
Fukuyama, S.2
|